Advertisement
Screener

Coya Therapeutics, Inc. (COYA) ROE

Coya Therapeutics, Inc. (COYA) ROE

  • 2026-06-30: ROE -50.07%.
  • 2026-03-31: ROE -43.14%.
  • 2025-12-31: ROE -49.33%.
  • 2025-09-30: ROE -67.56%.

Complete source-backed roe history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-50.07%
2026-03-31-43.14%
2025-12-31-49.33%
2025-09-30-67.56%
2025-06-30-71.84%
2025-03-31-51.35%
2024-12-31-37.60%
2024-09-30-33.42%
2024-06-30-28.65%
2024-03-31-31.81%
2023-12-31-22.42%
2023-09-30-122.53%
2023-06-30-97.83%
2023-03-31-82.20%
2022-12-31145.88%

Annual ROE

DateROE
2025-12-31-49.33%
2024-12-31-37.60%
2023-12-31-22.42%
2022-12-31145.88%
2021-12-31-134.25%

Similar stocks

Stock NameCountryMarket CapPE Ratio
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31